title: Polymorphisms in the estrogen receptor beta gene and risk of breast cancer: no association.
abstract: Polymorphisms in the estrogen receptor beta (ERbeta) gene may influence the cellular growth regulating effects of estradiol. In this first association study about breast cancer risk and polymorphisms in the ERbeta gene we have screened 219 Finnish sporadic breast cancer cases and 248 ethnically matched male controls. No difference in the allele distribution of the six studied polymorphisms was found between the breast cancer and control groups.
authors.affiliation: Department of Biosciences at Novum, Karolinska Institute, Huddinge, Sweden. asta.forsti@cnt.ki.se
authors.forename: Asta
authors.initials: A
authors.lastname: Försti
authors.forename: Chunyan
authors.initials: C
authors.lastname: Zhao
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Israelsson
authors.forename: Karin
authors.initials: K
authors.lastname: Dahlman-Wright
authors.forename: Jan-Ake
authors.initials: JA
authors.lastname: Gustafsson
authors.forename: Kari
authors.initials: K
authors.lastname: Hemminki
mesh_terms: D001943:Breast Neoplasms / Q000209:etiology* / Q000235:genetics*; D016022:Case-Control Studies; D002455:Cell Division; D047629:Estrogen Receptor beta; D005260:Female; D006801:Humans; D008297:Male; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic; D011960:Receptors, Estrogen / Q000235:genetics*; D012307:Risk Factors
chemical_list: D047629:Estrogen Receptor beta; D011960:Receptors, Estrogen